Conclusion

There was adequate knowledge about gout and management among patients. Knowledge, patient age, and management of gout had significant associations with gout status among these patients. Most of the patients had been diagnosed between the ages of 25 and 44 years. Patients’ chief complaints at the time of diagnosis had no associations with their gout statuses.
Conflict of Interest
Authors reported no conflict of interest.
Funding
The authors extend their appreciation to the deputyship for Research and innovation, Ministry of education in Saudi Arabia for funding this research work through the project number (IF-PSAU- 2021/03/17631)
Ethical Approval
This research had ethical approval from Prince Sattam bin Abdulaziz University Deanship of Scientific Research, Research Ethics committee in Health and Science Disciplines. Approval number (REC-HSD-99-2021)
Authors Contribution
AAK conceived and designed the study, conducted research, provided research materials, and commenced at writing initial and final draft of the article. AAB, AMM, AMA, RAA, ASA, TDA, NAA , AAA collected , organized , analyzed and interpreted data. Also, they provided logistic support. ALL authors have critically reviewed and approved the final draft and are responsible for the content and similarity index of the manuscript.
References
Ragab, G., Elshahaly, M., & Bardin, T. (2017). Gout: An old disease in new perspective - A review. Journal of Advanced Research, 8 (5), 495–511.https://doi.org/10.1016/j.jare.2017.04.008
Pascart, T., & Lioté, F. (2019). Gout: State of the art after a decade of developments.
Rheumatology (Oxford, England), 58(1), 27–44.https://doi.org/10.1093/rheumatology/key002
  1. Wu, M., Tian, Y., Wang, Q., & Guo, C. (2020). Gout: a disease involved with complicated immunoinflammatory responses: a narrative review. Clinical Rheumatology, 39 (10), 2849–2859.https://doi.org/10.1007/s10067-020-05090-8
  2. Bao, W., Xue, Y., Cheng, X., Wang, P., Yin, B., Su, Y., & Jia, C. (2022). Gout-associated uric acid crystals induce tophi ulcerations and impair wound healing in a novel gouty ulcer model. Wound Repair and Regeneration, 30 (1), 132–139.https://doi.org/10.1111/wrr.12973
  3. Kanwal, A., Abida, L., Sana, A., & Ahlam S. (2018). A systematic review on the prevalence, pathophysiology, diagnosis, management, and treatment of gout (2007-2018). GSC Biological and Pharmaceutical Sciences , 5(1), 050–055.https://doi.org/10.30574/gscbps.2018.5.1.0077
  4. Kuo, C. F., Grainge, M. J., Zhang, W., & Doherty, M. (2015). Global epidemiology of gout: Prevalence, incidence and risk factors.Nature Reviews. Rheumatology, 11 (11), 649–662.https://doi.org/10.1038/nrrheum.2015.91
  5. Smith, E. U., Díaz-Torné, C., Perez-Ruiz, F., & March, L. M. (2010). Epidemiology of gout: An update. Best Practice & Research. Clinical Rheumatology, 24 (6), 811–827.https://doi.org/10.1016/j.berh.2010.10.004
  6. Xia, Y., Wu, Q., Wang, H., Zhang, S., Jiang, Y., Gong, T., Xu, X., Chang, Q., Niu, K., & Zhao, Y. (2020). Global, regional and national burden of gout, 1990-2017: A systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford, England), 59 (7), 1529–1538.https://doi.org/10.1093/rheumatology/kez476
  7. Spaetgens, B., Pustjens, T., Scheepers, L. E. J. M., Janssens, H. J. E. M., van der Linden, S., & Boonen, A. (2016). Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: A mixed methods study in general practice. Clinical Rheumatology, 35 (8), 2053–2061.https://doi.org/10.1007/s10067-016-3212-2
  8. Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda, J., Coyfish, M., Guillo, S., Jansen, T., Janssens, H., Lioté, F., Mallen, C. D., Nuki, G., Perez-Ruiz, F., Pimentao, J., Punzi, L., Pywell, A., So, A. K., Tausche, A. K., . . . Bardin, T. (2020). 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Annals of the Rheumatic Diseases, 79 (1), 31–38.https://doi.org/10.1136/annrheumdis-2019-215315
  9. Gaffo, A. L., Dalbeth, N., Saag, K. G., Singh, J. A., Rahn, E. J., Mudano, A. S., Chen, Y. H., Lin, C. T., Bourke, S., Louthrenoo, W., Vazquez-Mellado, J., Hernández-Llinas, H., Neogi, T., Vargas-Santos, A. B., da Rocha Castelar-Pinheiro, G., Amorim, R. B. C., Uhlig, T., Hammer, H. B., Eliseev, M., . . . Taylor, W. (2018). Brief Report: Validation of a Definition of Flare in Patients With Established Gout.Arthritis & Rheumatology (Hoboken, N.J.), 70 (3), 462–467.https://doi.org/10.1002/art.40381
  10. Singh, J. A. (2014). The impact of gout on patient’s lives: a study of African-American and Caucasian men and women with gout.Arthritis Research & Therapy ,16(3), R132.https://doi.org/10.1186/ar4589
  11. Jin, J., Sklar, G. E., Min Sen Oh, V., & Chuen Li, S. (2008). Factors affecting therapeutic compliance: A review from the patient’s perspective. Therapeutics and Clinical Risk Management, 4 (1), 269–286.https://doi.org/10.2147/TCRM.S1458
  12. Moi, J. H., Sriranganathan, M. K., Edwards, C. J., & Buchbinder, R. (2013). Lifestyle interventions for chronic gout. Cochrane Database of Systematic Reviews , 2013(5), CD010039.https://doi.org/10.1002/14651858.CD010039.pub2
  13. Singh, J. A. (2009). Quality of life and quality of care for patients with gout. Current Rheumatology Reports, 11 (2), 154–160.https://doi.org/10.1007/s11926-009-0022-4
  1. Pascal T, Lioté F. Gout: state of the art after a decade of developments. Rheumatol. 2019; 58(1):27-44. doi: 10.1093/rheumatology/key002
  2. Wu M, Tian Y, Wang Q, Guo C. Gout: a disease involved with complicated immunoinflammatory responses: a narrative review. Clin Rheumatol. 2020; 39(10):2849-2859. doi: 10.1007/s10067-020-05090-8
  3. Bao W, Xue Y, Cheng X, Wang P, Yin B, Su Y, et al. Gout associated uric acid crystals induce tophi ulcerations and impair wound healing in a novel gouty ulcer model. Wound Repair Regen. 2022;30(1):132-139. doi: 10.1111/wrr.12973
  1. Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649-662. doi: 10.1038/nrrheum.2015.91
  2. Smith EU, Diaz-Torne C, Perez-Ruiz F, March LM. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol. 2010;24(6):811-827. doi: 10.1016/j.berh.2010.10.004
  3. Xia Y, Wu Q, Wang H, Zhang S, Jiang Y, Gong T, et al. Global, regional and national burden of gout, 1990–2017: a systematic analysis of the Global Burden of Disease Study. Rheumatol. 2020;59(7):1529-1538. doi: 10.1093/rheumatology/kez476
  4. Spaetgens B, Pustjens T, Scheepers LEJM, Janssens HJEM, van der Linden S, Boonen A. Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice. Clin Rheumatol. 2016;35(8):2053-2061. doi:10.1007/s10067-016-3212-2
  5. Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31-38. doi:10.1136/annrheumdis-2019-215315
  6. Gaffo AL, Dalbeth N, Saag KG, et al. Brief Report: Validation of a Definition of Flare in Patients With Established Gout. Arthritis Rheumatol. 2018;70(3):462-467. doi:10.1002/art.40381 14 Singh JA. The impact of gout on patient’s lives: a study of African-American and Caucasian men and women with gout. Arthritis Res Ther. 2014;16(3):R132. Published 2014 Jun 24. doi:10.1186/ar4589
15 Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-286. doi:10.2147/tcrm.s1458 16 Moi JH, Sriranganathan MK, Edwards CJ, Buchbinder R. Lifestyle interventions for chronic gout. Cochrane Database Syst Rev. 2013;2013(5):CD010039. Published 2013 May 31. doi:10.1002/14651858.CD010039.pub2 17 Singh J. A. (2009). Quality of life and quality of care for patients with gout. Current rheumatology reports, 11(2), 154–160. https://doi.org/10.1007/s11926-009-0022-4